Diebold Nixdorf, Incorporated

NYSE:DBD

Software - Application

Technology
$52.75 +2.11%

+$1.71 today

Market cap
$1.77B
Beta
1.13
P/E (TTM)
26.9
EPS (TTM)
$3.07
52W Low $51.46High $89.05

Volume 0.27M

Average 0.43M

DBD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Diebold Nixdorf, IncorporatedNYSE: DBD

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development declines year over year

Q2 FY2026 research & development of $20.5M fell 7.7% year over year, ahead of the -8.3% change in trailing-twelve-month research & development. Sequentially, it fell 7.2% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.

Context

  • Research & development amounted to 2.2% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -7.7% holds above the trailing-twelve-month pace of -8.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$20.5M-7.2% QoQ
Last fiscal yearDec 2025
$83.8M-10.5% YoY
LTMJun 2026
$83.9M-8.3% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-7.7%——
1 year-10.5%——
3-year CAGR-11.5%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
83.8M USD
Year-over-year change
-10.5%
4-year CAGR
-9.7%

Research & Development vs competitors

How DBD compares with its peers on the latest reported figures

  • DBD's LTM Jun 2026 research & development of $83.9M is the 6th highest of the 10 companies compared; the peer median is $96.55M.
  • Its year-over-year change of -8.3% is the lowest of 7, against a peer median of +12.7%.
  • Research & development amounts to 2.2% of revenue for DBD, versus a peer median of 13.7%.
DBD Competitors Peer median
Research & Development for DBD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALRMAlarm.com Holdings, Inc.LTM Sep 2026$278.95M +4.8%+7.3%25.7%
PRGSProgress Software CorporationLTM Feb 2026$196.36M +24.5%+18.8%19.9%
APPNAppian CorporationLTM Sep 2026$189.33M +20.3%+7.3%22.5%
ALKTAlkami Technology, Inc.LTM Mar 2026$122.51M +22.2%+19.5%26.0%
CXMSprinklr, Inc.LTM Apr 2026$96.55M +5.1%+7.8%11.1%
DBDDiebold Nixdorf, IncorporatedLTM Jun 2026$83.9M -8.3%-11.5%2.2%
EVCMEverCommerce Inc.LTM Jun 2026$82.15M +4.3%+3.3%13.7%
NPNeptune Insurance Holdings Inc.LTM Jun 2026$0 ——0.0%
PLUSePlus inc.LTM Sep 2026$0 ——0.0%
WBTNWEBTOON Entertainment Inc. Common stockLTM Mar 2026$0 ——0.0%
Peer median (excluding DBD) $96.55M+12.7%+7.6%13.7%

Competitors are the stored peer set for DBD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.91B3.46B3.76B3.75B3.81B
Cost of Revenue2.86B2.7B2.88B2.83B2.8B
Gross Profit1.04B757.3M876.2M920M1B
Gross Margin26.7%21.9%23.3%24.5%26.4%
Research & Development126.3M120.7M110.9M93.6M83.8M
Selling, General & Admin775.6M741.6M0643.6M585M
Operating Expenses906.3M969M789.3M737.9M668.8M
Depreciation & Amortization149.1M126M136.3M132.3M127.5M
EBITDA293.7M(113.4M)284.9M334.9M334.8M
EBITDA Margin7.5%-3.3%7.6%8.9%8.8%
Operating Income137.1M(211.7M)86.9M182.1M334.6M
Operating Margin3.5%-6.1%2.3%4.9%8.8%
Interest Income6.1M10M13M12.3M8.9M
Interest Expense195.3M199.2M246.2M155.3M85.7M
Other Income / Expenses(187.5M)(224.7M)1.37B(132.3M)(213M)
Income Before Tax(50.4M)(436.4M)1.45B49.8M121.6M
Pre-Tax Margin-1.3%-12.6%38.6%1.3%3.2%
Income Tax Expense27.7M149.2M75.7M64.3M24.1M
Net Income(78.8M)(581.4M)1.38B(16.5M)94.6M
Net Margin-2.0%-16.8%36.6%-0.4%2.5%
EPS (Basic)(1.00)(7.44)21.38(0.44)2.57
EPS (Diluted)(1.00)(7.44)21.38(0.44)2.54
Weighted Avg Shares78.3M79M64.36M37.6M36.8M
Weighted Avg Shares (Diluted)78.3M79M64.36M37.6M37.2M

Diebold Nixdorf, Incorporated

NYSE:DBD

Intrinsic Alpha fair value

Locked

Current Price

$52.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.